HRT FINANCIAL LP

Position in VKTX — Viking Therapeutics, Inc.

CIK 1475597 NEW YORK, NY

Position in VKTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,122,069

-$1,021,110 QoQ

Shares Held

105,667

-46.0% QoQ

Ownership

0.091%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#80

of 435 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. VKTX ranks #42 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,122,069	105,667	-46.0%	Shares	Defined	2026-08-14
2025-09-30	$5,143,179	195,707	+115.2%	Shares	Defined	2025-11-14
2025-06-30	$2,409,645	90,930	+75.1%	Shares	Defined	2025-08-14
2025-03-31	$1,253,940	51,923	-86.9%	Shares	Defined	2025-05-15
2024-06-30	$21,022,864	396,583	+217.3%	Shares	Defined	2024-08-12
2023-12-31	$2,325,710	124,971	-53.9%	Shares	Defined	2024-02-09
2023-03-31	$4,516,395	271,255	-28.5%	Shares	Defined	2023-05-12
2022-12-31	$3,567,920	379,566	+115.5%	Shares	Defined	2023-02-10
2022-06-30	$509,119	176,166	-24.7%	Shares	Defined	2022-08-12
2022-03-31	$702,198	234,066	+111.0%	Shares	Defined	2022-05-16
2021-12-31	$510,406	110,958	+56.8%	Shares	Defined	2022-02-14
2021-09-30	$444,341	70,755	+245.4%	Shares	Defined	2021-11-15
2021-06-30	$122,699	20,484	+21.9%	Shares	Defined	2021-08-16
2020-12-31	$94,589	16,801	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.